Mangalam Drugs And Stock Fundamentals
| MANGALAM | 77.51 1.89 2.50% |
Mangalam Drugs And fundamentals help investors to digest information that contributes to Mangalam Drugs' financial success or failures. It also enables traders to predict the movement of Mangalam Stock. The fundamental analysis module provides a way to measure Mangalam Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mangalam Drugs stock.
At present, Mangalam Drugs' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 168 M, whereas Total Revenue is forecasted to decline to about 2.6 B. Mangalam | Select Account or Indicator |
Mangalam Drugs And Company Return On Asset Analysis
Mangalam Drugs' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mangalam Drugs Return On Asset | 0.005 |
Most of Mangalam Drugs' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mangalam Drugs And is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Mangalam Total Assets
Total Assets |
|
Based on the latest financial disclosure, Mangalam Drugs And has a Return On Asset of 0.005. This is 100.06% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all India stocks is 103.57% lower than that of the firm.
Mangalam Drugs And Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mangalam Drugs's current stock value. Our valuation model uses many indicators to compare Mangalam Drugs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mangalam Drugs competition to find correlations between indicators driving Mangalam Drugs's intrinsic value. More Info.Mangalam Drugs And is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Mangalam Drugs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mangalam Drugs' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Mangalam Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mangalam Drugs' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mangalam Drugs could also be used in its relative valuation, which is a method of valuing Mangalam Drugs by comparing valuation metrics of similar companies.Mangalam Drugs is currently under evaluation in return on asset category among its peers.
Mangalam Fundamentals
| Return On Equity | -0.0631 | ||||
| Return On Asset | 0.005 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.9 B | ||||
| Shares Outstanding | 15.83 M | ||||
| Shares Owned By Insiders | 54.58 % | ||||
| Price To Book | 0.84 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 3.67 B | ||||
| Gross Profit | 1.17 B | ||||
| EBITDA | 139.86 M | ||||
| Net Income | (90.72 M) | ||||
| Cash And Equivalents | 917.4 M | ||||
| Total Debt | 1.07 B | ||||
| Book Value Per Share | 85.79 X | ||||
| Cash Flow From Operations | 39.13 M | ||||
| Earnings Per Share | (4.03) X | ||||
| Number Of Employees | 432 | ||||
| Beta | 0.75 | ||||
| Market Capitalization | 1.69 B | ||||
| Total Asset | 3.34 B | ||||
| Retained Earnings | 867.33 M | ||||
| Working Capital | 119.39 M | ||||
| Net Asset | 3.34 B |
About Mangalam Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mangalam Drugs And's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mangalam Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mangalam Drugs And based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 53.6 M | 63.7 M | |
| Total Revenue | 4.2 B | 2.6 B | |
| Cost Of Revenue | 4 B | 4.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.